期刊文献+

RNPC1基因对乳腺癌细胞MCF-7阿霉素药物敏感性的影响 被引量:4

Effects of RNPC1 on the sensitivity of breast cancer cell MCF-7 with doxorubicin
下载PDF
导出
摘要 目的 :研究RNPC1对乳腺癌细胞MCF-7阿霉素药物敏感性的影响。方法 :在MCF-7细胞中使用慢病毒转染法,设敲除(sh RNPC1)组和过表达RNPC1组、敲除对照(SCR)组和过表达对照(NC)组。用实时荧光定量PCR和Western blot法检测各组MCF-7细胞中RNPC1的m RNA和蛋白水平。以不同浓度的阿霉素处理各组MCF-7细胞,CCK-8法检测各组细胞生长抑制率。阿霉素处理各组MCF-7细胞后,用流式细胞术检测各组细胞凋亡率,Western blot法检测各组细胞中调亡相关蛋白的表达。结果:sh RNPC1组RNPC1 m RNA和蛋白相对表达量均低于SCR组,过表达RNPC1组RNPC1 m RNA及蛋白相对表达量均高于NC组(P<0.05)。阿霉素处理各组MCF-7细胞后,sh RNPC1组IC50明显于低于SCR组(P<0.05),过表达组IC50明显高于NC组(P<0.05)。阿霉素处理各组MCF-7细胞24 h后,发现sh RNPC1组凋亡率明显高于SCR组;过表达RNPC1组凋亡率显著低于NC组(P<0.05)。阿霉素处理各组MCF-7细胞24 h后,sh RNPC1组抑凋亡蛋白BCL-XL、BCL-2的表达低于SCR组,促凋亡蛋白BIM和BID的表达高于SCR组;过表达RNPC1组抑凋亡蛋白BCL-CL、BCL-2的表达高于NC组,促凋亡蛋白BIM和BID的表达低于NC组。结论:RNPC1能降低乳腺癌细胞MCF-7对阿霉素的敏感性,其机制与抗细胞凋亡有关。 Objective: To investigate the effects of RNPC1 on the sensitivity of breast cancer cell MCF-7 with doxorubicin (DOX).Methods: Lentivirus was used to over-express and knock-down RNPC1 in the MCF-7 breast cancer cells.The cells were divided into overexpress RNPC1 (RNPC1) group and its control (NC group),knock-down RNPC1 (sh RNPC1 group) and its control (SCR group).The relative m RNA and protein expression of RNPC1 was detected by q RT-PCR and Western blot,respectively.The experimental groups were treated with different concentration of DOX,and cell growth inhibition rate was tested cell counting kit 8 (CCK-8).After the experimental groups was treated with DOX,cell apoptosis rate was analysis by flow cytometer assay and the expression of apoptosis-related protein was detected by Western blot assay.Results: The q RT-PCR and Western blot results showed that the m RNA and protein level of RNPC1 was increased after transfection with RNPC1 overexpression (RNPC1).While,RNPC1 was reduced after transfection with knockdown RNPC1 (sh RNPC1) lentivirus.After treatment with different concentration of DOX,the IC50 of sh RNPC1 group was significantly lower than SCR group (P 0.05).Furthermore,the IC50 of RNPC1 group was higher than NC group (P0.05).The flow cytometer assay was used after treatment with DOX for 24 h in the experimental groups.The cell apoptosis rate of sh RNPC1 group was higher than SCR group,while,the cell apoptosis rate of RNPC1 was lower than NC group.Overexpression of RNPC1 increased the expression of BCL-XL and BCL-2 after treatment with DOX.Reversely,knockdown of RNPC1 reduced the expression of BCL-XL and BCL-2.Furthermore,overexpression of RNPC1 reduced the expression of BIM and BID after treatment with DOX.While,knockdown of RNPC1 increased the expression of BIM and BID.Conclusion: RNPC1 could decrease the sensitivity of breast cancer cell MCF-7to DOX,and the underlying mechanism might be related to cell apoptosis.
出处 《南京医科大学学报(自然科学版)》 CSCD 北大核心 2017年第9期1099-1103,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金(81572595)
关键词 RNPC1 乳腺癌 阿霉素 药物敏感性 RNPC1 breast cancer doxorubicin drug sensitivity
  • 相关文献

参考文献1

二级参考文献15

  • 1Cilri A, Yarden Y. EGF-ERBB signralling: towmts the systems level [J]. Nat Rev Mol Cell Biol, 2006. 7(7):505-516.
  • 2Menard S, Casalini P, Campiglio M, el al. Role of HER2/ncu in lumor progression and therapy[ J ]. Cell Mol Life Sci. 2004, 61 ( 23 ) : 2965-2978. DOI : 10.1007/s00018-004-4277-7.
  • 3Hubalek M, Brunner C, Matlhii K, et al. Resislan,.'e to, HER2- targeled therapy: mechanisms of trasluzumat) resislance and possible slralegies to overeonle unresponsiveness to treatment [ J ]. Wien Med Wochensehr, 2010, 160(19-20) :506-512. DOI: 10. 1007/s 10354-010-0838 -6.
  • 4Wdks ST. Potential of overcoming resistance to HER2-targeted therapies through the PI3K/AklfmTOR pathway[ J]. Breast, 2015, 24(5) : 548-555. DOI : 10.1016/j.breast.2015.06.002.
  • 5Zhang M, Zhang J, Chen X, et al. Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1 [J]. Genes Dev, 2013, 27(20):2246-2258. DOI:10.1101/gad. 221739.113.
  • 6Cho SJ, Zhang J, Chen X. RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability[J]. Nucleic Acids Res, 2010, 38(7) :2256-2267. DOI: i 0.1093/nar/gkp 1229.
  • 7Junttila TT, Akita RW, Parsons K, et al. Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by thePI3K inhibitor GDC-0941 [ J ]. CancerCell, 2009, 15 ( 5 ) : 429-440. DOI : 10.1016/j.ccr.2009,03.020.
  • 8Wong D J, Hurvitz SA. Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugates [ J ]. Ann Transl Med, 2014, 2(12) : 122. DOI: 10.3978/j.issn.2305-5839. 2014.08.13.
  • 9Ciafr SA, Galardi S. mieroRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer[J]. RNA Biol, 2013, 10(6):935-942. DOI: 10.4161/ rna.24641.
  • 10Xue JQ, Xia TS, Liang XQ, et al. RNA-binding protein RNPC1 : acting as a tumor suppressor in breast cancer [ J ]. BMC cancer, 2014, 14:322. DOI:10.1186/1471-2407-14-322.

共引文献9

同被引文献8

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部